48,830
edits
Line 214: | Line 214: | ||
==Subtyping breast cancer== | ==Subtyping breast cancer== | ||
===DCIS versus LCIS=== | |||
Stains: | |||
*E-cadherin +ve DCIS, -ve LCIS.<ref name=pmid18318578>{{cite journal |author=Yeh IT, Mies C |title=Application of immunohistochemistry to breast lesions |journal=Arch. Pathol. Lab. Med. |volume=132 |issue=3 |pages=349-58 |year=2008 |month=March |pmid=18318578 |doi= |url=http://journals.allenpress.com/jrnlserv/?request=get-abstract&issn=0003-9985&volume=132&page=349}}</ref> | |||
*34betaE12 +ve perinuclear LCIS, -ve DCIS.<ref name=pmid18318578/> | |||
*CAM5.2 peripheral stain = DCIS, perinuclear stain = LCIS.<ref name=pmid18318578/> | |||
**CAM5.2 is against CK8. | |||
*Beta-catenin -ve LCIS, +ve DCIS.<ref name=pmid18318578/> | |||
===Lymphovascular invasion=== | |||
* | {{Main|Lymphovascular invasion}} | ||
*D2-40 - marks the lymphatic spaces.<ref>{{cite journal |author=Ordóñez NG |title=Podoplanin: a novel diagnostic immunohistochemical marker |journal=Adv Anat Pathol |volume=13 |issue=2 |pages=83-8 |year=2006 |month=March |pmid=16670463 |doi=10.1097/01.pap.0000213007.48479.94 |url=}}</ref><ref>{{cite journal |author=Kahn HJ, Marks A |title=A new monoclonal antibody, D2-40, for detection of lymphatic invasion in primary tumors |journal=Lab. Invest. |volume=82 |issue=9 |pages=1255-7 |year=2002 |month=September |pmid=12218087 |doi= |url=}}</ref> | |||
==Treatment-related markers - overview== | ==Treatment-related markers - overview== |
edits